Allergan Deal May Set Stage For More Tribal Patent Pacts
A recent deal struck to shield Allergan PLC's patents for dry eye medication Restasis behind a New York tribe's sovereign immunity is drawing fire from generic-drug makers and others who claim...To view the full article, register now.
Already a subscriber? Click here to view full article